Effects of nurse-led intervention programs based on King’s theory of goal attainment on health-promoting behaviors and life satisfaction in patients with type 2 diabetes: a randomized controlled clinical trial

期刊论文
出版模式：

开放获取
发表日期：

2024年9月27日

查看全文

Fahime Noroozi,
Azizallah Dehghan,
Mostafa Bijani,
Leila Nikrouz

摘要

Background

Type 2 diabetes being a chronic condition that requires long-term care. This study examined the impact of an educational program using King’s goal attainment model on health behaviors and life satisfaction in type 2 diabetes patients.

Methods

This is a randomized controlled clinical trial with no blinding in which we tested two groups of intervention control. 70 patients with type 2 diabetes were allocated to an intervention (N = 35) and a control group randomly (N = 35). The nursing process stages included examination, diagnosis, goal determination, transaction based on patient preferences, and evaluation based on King’s theory. Data was gathered using the Walker Health-Promoting Lifestyle Profile (HPLP) and Satisfaction with Life Scale (SWLS, before, after, and 3 months, post-intervention. Data were analyzed in SPSS25 through descriptive statistics, Chi-square Test, Independent and paired sample T-test, two-way ANOVA, and multivariate repeated measures ANCOVA. P-values < 0.05 were considered as the level of significance.

Results

In the intervention group, there was a significant difference in the mean score of health-promoting behaviors and life satisfaction between the three time points (before, immediately after, and 3 months after). However, in the control group, there was no significant difference in the mean score of health-promoting behaviors and life satisfaction.

Conclusion

The results of this study suggest that an educational program based on King’s goal attainment model can be effective in improving health-promoting behaviors and life satisfaction in patients with type 2 diabetes. Further studies are recommended to be conducted in different settings and with a longer follow-up period.

Iranian registry of clinical trials

IRCT registration number: IRCT20190917044802N8.

Registration date

16/12/2022.